Shorts

0:36
A Promising Breakthrough in Platinum-Resistant Ovarian Cancer Survival
6 months ago
by
Alexander Olawaiye, MD

0:34
IMNN-001: A Broader Approach to Immunotherapy
6 months ago
by
Premal Thaker, MD, MS

0:55
Cultivating A Culture of Clinical Trials in Pediatrics
6 months ago
by
E. Anders Kolb, MD(+1 more)

0:53
Dr Wang on Managing Post-CAR T Infections: Act Fast and Coordinate Care
6 months ago
by
Michael Wang, MD

0:43
Why Children Are Not Just ‘Little Adults’ in Cancer Treatment
6 months ago
by
E. Anders Kolb, MD(+1 more)

0:33
Dr Wang: Check IgG Early to Prevent Infections After CAR T
7 months ago
by
Michael Wang, MD

0:29
Closing the Gap Between Immunotherapy Innovation and Outdated Evaluation Standards
7 months ago
by
Richard Goldberg, MD

0:53
Dr Thaker Highlights Personalized PARP Strategies and the Promise of IMNN-001 in Ovarian Cancer
7 months ago
by
Premal Thaker, MD, MS

0:49
Giving Patients the Power to Choose
7 months ago
by
Abdulraheem Yacoub, MD

0:36
ROSELLA Shows Survival Benefit With Convenient Relacorilant Dosing
7 months ago
by
Alexander Olawaiye, MD

0:30
BTK Degraders: A New Hope for Resistant CLL
7 months ago
by
Nicole Lamanna, MD

0:34
A New Alternative to Phlebotomy
7 months ago
by
Abdulraheem Yacoub, MD

1:08
Promising Responses in Ewing Sarcoma Trial
7 months ago
by
Rashmi Chugh, MD

0:33
Why Residual Cancer Burden is a Game-Changer for Oncology
7 months ago
by
Lajos Pusztai, MD, PhD

0:40
Treating High-Risk CLL: Balancing Efficacy and Duration
7 months ago
by
Nicole Lamanna, MD

0:35
Why BRAF Testing Is Critical in ATC
7 months ago
by
Nabil Saba, MD

0:47
Rare but Targetable: Advances in Biliary Tract Cancer
7 months ago
by
Linda Y. Wu, MD

0:37
The Sequencing Dilemma in Thyroid Cancer
7 months ago
by
Nabil Saba, MD

1:04
Future-Proofing Treatment in Younger Patients With CLL
7 months ago
by
Nicole Lamanna, MD

0:48
Tackling Resistance in Pancreatic Cancer
7 months ago
by
Linda Y. Wu, MD

0:36
Patient Preference: The Heart of CLL Treatment Decisions
7 months ago
by
Nicole Lamanna, MD

0:43
Why Every Thyroid Cancer Patient Needs Genomic Analysis
7 months ago

0:41
What is the Role of PCI in LS-SCLC?
7 months ago
by
Raj Singh, MD

1:01
Combining KRAS Inhibition With Immunotherapy in NSCLC
7 months ago
by
Jamie E. Chaft, MD

0:54
Evolving Clinical Utility of ctDNA in Upper GI Cancer Care
7 months ago
by
Ryan H. Moy, MD, PhD

0:36
Dr Raj Singh on Advances in Head and Neck Cancer Therapy
7 months ago
by
Raj Singh, MD

0:46
Unlocking the Secrets of Breast Cancer Mutations
7 months ago
by
Pedram Razavi, MD, PhD

1:05
The Huge Unmet Need: CNS Efficacy in Lung Cancer Drugs
7 months ago
by
Helena Yu, MD

0:49
The Danger of Relying Solely on Negative ctDNA Tests
7 months ago
by
Catherine T. Haring, MD

0:57
Can Myeloma Treatment Be Done at Home?
7 months ago
by
Sikander Ailawadhi, MD
Advertisement
Advertisement
Trending on Targeted Onc
1
FDA Approves Neladalkib for Previously Treated Advanced ALK-Positive NSCLC
2
Galinpepimut-S Improves Overall Survival in Phase 3 REGAL Trial in AML
3
FDA Approves Giredestrant Plus Everolimus in ESR1-Mutated Breast Cancer
4
FDA Fast Tracks Elticertinib for Previously Treated EGFR Exon 20 NSCLC
5
